Commerzbank's Valuation Reset: RBC Trims Its Target as Brussels Sets a November 16 Clock

RBC downgraded Commerzbank to Sector Perform and cut its target to EUR 40, as UniCredit filed for EU antitrust review with a Nov 16 deadline.

Two separate threads are pulling at Commerzbank shareholders this month, and they answer to different authorities. One runs through Brussels, where UniCredit has formally filed for EU antitrust clearance of its takeover ambitions. The other runs through the equity research desks, where RBC Capital Markets has taken a more cautious view of what the stock is worth while that process plays out.

RBC steps back from its bullish stance

RBC Capital Markets downgraded Commerzbank from "Outperform" to "Sector Perform" on October 2, according to media reports. The reasoning ties a higher cost of equity to the uncertainty surrounding UniCredit, meaning the call is not simply about whether a deal happens but about how hard it is to price the risk along the way.

The broker cut its price target from EUR 43 to EUR 40. That is a more conservative assessment, not a verdict on how the takeover will end. Difficulty in calculating the risks forms a central part of the rationale.

For investors, the distinction matters: a possible takeover and an attractively valued stock are not automatically the same thing. RBC's move shows that uncertainty can feed directly into the valuation framework, independent of the deal's eventual fate.

UniCredit files, and Brussels picks a date

Reuters reported that UniCredit has submitted the transaction for antitrust review. The European Commission has set November 16 as its deadline for deciding on the plans for Commerzbank.

That date gives the process a concrete reference point, though it does not answer the question of the outcome. Nor does the filing itself amount to an approval already granted. The risks RBC flagged and the regulatory timetable therefore operate on different levels of the same takeover constellation.

BlackRock's stake notice covers instruments, not just shares

On Wednesday, BlackRock reported a total holding of 4.38% of Commerzbank voting rights and equivalent instruments, down from a previously reported 4.49%. The change reflects the position as of October 2, not the day the disclosure was published.

The figure explicitly includes both voting rights and corresponding instruments, so it should not be equated with a stake consisting solely of directly held shares. The disclosure also stands apart from the approval process UniCredit has set in motion: both items concern Commerzbank, but they describe different matters.

Buyback keeps running alongside the headlines

The bank continued its ongoing share repurchase program in parallel. Between September 28 and October 2 inclusive, it bought back 1,871,048 of its own shares. Across the program to date, the total acquired reached 8,126,141 by the end of that period.

The buyback is a capital measure taken by Commerzbank itself, while the BlackRock filing describes an ownership position. Neither disclosure yields a European Commission decision on the takeover plan.

A business date lands before the regulatory one

Third-quarter 2026 results are scheduled for release on November 5, ahead of the Commission's decision deadline. Investors therefore get a business milestone first and a regulatory one afterward.

The two events carry different emphases. The earnings release speaks to Commerzbank's economic performance; the EU procedure concerns antitrust clearance for UniCredit's plan.

The takeaway: the stake disclosure, the buyback and the takeover review each deserve separate assessment. UniCredit's application sharpens the regulatory sequence, while the scheduled quarterly figures provide the next business anchor. None of these announcements substitutes for the others.